RCT of AF ablation vs rate control in HFrEF with CMR Ventricular fibrosis at late breakers this Sunday ⁦Sandeep Prabhu⁩ ⁦louise⁩ ⁦University of Melbourne⁩ Heart Centre at the Alfred⁩ #ESC2024

Do patients with AF mediated CM need to continue heart failure meds after AF ablation? Find out tomorrow #ESCCongress ⁦louise⁩ ⁦Sandeep Prabhu⁩ ⁦Heart Centre at the Alfred⁩

Significant benefit also after >2years of follow up in #CASTLEHTx. Extended FU presented by Christian Sohns at #ESCCongress HDZ NRW Young DGK AGEP Deutsche Gesellschaft für Kardiologie Read the results in Circulation

A reduction in polypharmacy to Carvedilol alone in recovered LVEF appears safe #ESCCongress

Not all HF is equal! Withdrawing HF pharmacotherapy in patients with a clear AF mediated CM and normalisation of LVEF appears safe and feasible. louise European Society of Cardiology peterkistler MBBS PhD FHRS Baker Institute The Alfred

Baker Institute louise peterkistler MBBS PhD FHRS Sandeep Prabhu #ESC2024

Results of the CAMERA-MRI II study LBCT #ESC2024: catheter ablation in AF and LVSD with LV fibrosis superior to medical therapy with respect to LVEF improvement, functional status, patient symptoms and reverse LA remodeling European Society of Cardiology News John Mandrola, MD peterkistler MBBS PhD FHRS Sandeep Prabhu

CAMERA MRI 2: RCT: AF ablation ⬆️LVEF of 21%, VO2 MAX, QOL & ⬇️HF Hospital in HFrEF LGE + on CMR vs med rate control #ESCCongress ⁦Sandeep Prabhu⁩ ⁦louise⁩ ⁦Heart Centre at the Alfred⁩

Patients with HF, LV scar and AF demonstrate significant LV and functional improvements post ablation compared to drugs. Results of CAMERA-MRI2 released at ESC 2024 London LBCT session. #ESCCongress2024 louise peterkistler MBBS PhD FHRS Baker Institute The Alfred